Ayala Pharmaceuticals Inc (AYLA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2021 | 03-2021 | 12-2020 | 09-2020 | 06-2020 | |
| Sales | 761 | 974 | 1,004 | 658 | 1,045 |
| Cost of Goods | 761 | 974 | 1,004 | 658 | 1,045 |
| Operating Expenses | 11,418 | 10,202 | 9,446 | 7,941 | 6,658 |
| Operating Income | -10,657 | -9,228 | -9,442 | -7,283 | -6,613 |
| Other Income | -22 | -92 | 94 | -40 | 40 |
| Pre-tax Income | -10,679 | -9,320 | -9,348 | -7,323 | -6,573 |
| Income Tax | 162 | 248 | 50 | 115 | 139 |
| Net Income Continuous | -10,841 | -9,568 | -9,398 | -7,438 | -6,712 |
| Net Income | $-10,841 | $-9,568 | $-9,398 | $-7,438 | $-6,712 |
| EPS Basic Total Ops | -0.75 | -0.74 | -0.41 | -0.59 | -0.74 |
| EPS Basic Continuous Ops | -0.75 | -0.74 | -0.41 | -0.59 | -0.74 |
| EPS Diluted Total Ops | -0.75 | -0.74 | -0.41 | -0.59 | -0.74 |
| EPS Diluted Continuous Ops | -0.75 | -0.74 | -0.41 | -0.59 | -0.74 |
| EPS Diluted Before Non-Recurring Items | -0.75 | -0.74 | N/A | N/A | N/A |
| EBITDA(a) | $-10,727 | $-9,064 | $-9,398 | $-7,234 | $-6,577 |